About us
Our Mission
We exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with our four-in-one biologic drug, AUP-16.
Our Vision
Our goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by end of 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients.